Skip to content
Study details
Enrolling now

Sana Device for Chronic Pain

Icahn School of Medicine at Mount Sinai
NCT IDNCT06655844ClinicalTrials.gov data as of Apr 2026
Target enrollment

30

Study length

about 1.5 years

Ages

18+

Locations

1 site in NY

About this study

Researchers are testing a device called Sana Pain Reliever (Sana PR) to see if it helps reduce chronic pain in people who have had Lyme disease and are still experiencing pain. The Sana PR is a wearable device that uses light pulses, tones, and HRV sensors to provide treatment. The trial will last for 14 weeks.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Use Sana Pain Reliever
  • 2.Use Sham SPR
Primary goalNeuropathic Pain Symptom Inventory

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low6%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Neuropathic Pain Symptom Inventory

Secondary: Beck Depression Inventory (BDI), General Anxiety Disorder 7-item questionnaire (GAD-7), Pittsburgh Sleep Quality Index (PSQI), Visual analogue scale (VAS)- Pain, Visual analogue scale (VAS)- Sleep